KBI Biopharma has completed the acquisition of the assets of Elion Labs. Elion’s services include analytical method development, qualification and validation, characterization of biologics, and comprehensive data analysis including visualization and interpretation of complex data sets.   This acquisition further strengthens KBI’s analytical and biophysical characterization capabilities following the company’s acquisition of Alliance Protein Laboratories in June 2017.  All of Elion’s staf...